| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 06/27/2002 | WO2001073025A3 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 06/27/2002 | WO2001062894A3 Process for production of carotenoids, xanthophylls and apo-carotenoids utilizing eukaryotic microorganisms |
| 06/27/2002 | WO2001038358A9 Hbv/hcv virus-like particle |
| 06/27/2002 | US20020083492 Basidiomycete peroxidase gene-transferred plant and a method for decomposing and removing hazardous chemicals using the same |
| 06/27/2002 | US20020083488 Mutating nucleotide sequences; obtain nucleotide sequence, incubate with mutant primers and polymerase, amplify nucleotide sequence, digest recover product, screen for primer sequences |
| 06/27/2002 | US20020082414 Membrane protein for use in controlling vasodilation |
| 06/27/2002 | US20020082397 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 06/27/2002 | US20020082385 Protein for use in dietetics and the treatment of diabebtes |
| 06/27/2002 | US20020082234 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020081724 Culture of stem cells; for use in human therapeutics |
| 06/27/2002 | US20020081723 Respiratory syncytial virus (RSV) fusion protein; treating or preventing RSV infection, as well as for diagnosis of RSV in analytes |
| 06/27/2002 | US20020081695 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 06/27/2002 | US20020081690 Hybrid enzyme and use thereof |
| 06/27/2002 | US20020081676 Method for producing an oxide with a fermentation process |
| 06/27/2002 | US20020081665 Composition for use as immunomodulatory and anticarcinogenic agents |
| 06/27/2002 | US20020081664 Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 06/27/2002 | US20020081646 Production method of polyhydroxyalkanoate form substituted fatty acid ester as raw material |
| 06/27/2002 | US20020081601 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 06/27/2002 | US20020081576 Antibodies directed against binding-associated epitopes |
| 06/27/2002 | US20020081574 Enzymatic polypeptide for use in the diagnosis, prevention and treatment of viral disease |
| 06/27/2002 | US20020081314 Starch and protein from a mixture of embryo bud and seed coat of rice and fruit body of ganoderma lucidum are decomposed by aspergills oryzae with added B vitamins, and the enzyme retain their catalytic activity; prevent autoimmune diabetes |
| 06/27/2002 | US20020081299 Hair cell disorders |
| 06/27/2002 | US20020081288 A polypeptide selected from the group consisting of a SOD-4 polypeptide (superoxide dimutase) having a preferred deduced amino acid sequence and fragments, analogs and derivatives encoded by a specific polynucleotide |
| 06/27/2002 | US20020081279 In vitro manipulation of a plasmid-cloned chicken embryo lethal orphan (CELO) virus DNA, suitable for the production of vectors for gene therapy and as a vaccine against infectious diseases in human and animals, particularly birds |
| 06/27/2002 | CA2431990A1 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/26/2002 | EP1217067A2 Connective tissue growth factor-2 |
| 06/26/2002 | EP1216710A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 06/26/2002 | EP1216054A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 06/26/2002 | EP0773785B1 Treatment of cancer using hsv mutant |
| 06/26/2002 | EP0578761B1 Enzymatic process for the production of cefonicid |
| 06/26/2002 | EP0574391B1 Antibodies against the urokinase receptor and their use |
| 06/26/2002 | EP0464147B1 Matrix metalloproteinase inhibitor peptides |
| 06/26/2002 | CN1355846A Method for down-regulating IL5 activity |
| 06/26/2002 | CN1355842A Methods for making proteins containing free cysteine residues |
| 06/26/2002 | CN1355812A Pseudomycin analogs |
| 06/26/2002 | CN1355673A Novel protective cultures and use thereof for preserving foodstuffs |
| 06/26/2002 | CN1355295A Method for producing threonine and isolenine |
| 06/26/2002 | CN1086738C Process for preparing alpha-hydroxy acids using microorganism and novel microorganism |
| 06/25/2002 | USRE37767 Highly stable recombinant yeasts for the production of recombinant proteins |
| 06/25/2002 | USRE37766 K. lactis pyruvate-decarboxylase promoter and use thereof |
| 06/25/2002 | US6410705 Nucleotide sequences coding enzymatic polypeptide for use in the generation of threonine; for use in preparation of animal nutrients, human medicine and pharmacology |
| 06/25/2002 | US6410691 Monoclonal antibody for use in diagnosis and treatment of immunlogical defects, cancer and rheumatic diseases |
| 06/25/2002 | US6410685 Reducing stress in mammals; obtain mammal, administer tripeptide, monitor mammal for reduction in products of stress response |
| 06/25/2002 | US6410318 Antibodies directed against binding-associated epitopes |
| 06/25/2002 | US6410316 Methods for producing a vector producing cell line utilizing a high multiplicity of transduction |
| 06/25/2002 | US6410303 Yeast culture with amplified shelf-life for use in baked goods |
| 06/25/2002 | US6410297 Processes for preparation of Marek's disease virus using continuous avian cell lines |
| 06/25/2002 | US6410296 Herpes virus proteinase and method of assaying |
| 06/25/2002 | US6410293 DNA fragments containing biotin biosynthetase gene and use of the same |
| 06/25/2002 | US6410273 Generating methylated nucleotide sequences; obtain prokaryotc cell, transform with nucleotide sequences and expression vector, culture cells, recover methylated nucleotide sequences |
| 06/25/2002 | US6410270 Process for the preparation of recombinant proteins in E. coli by high cell density fermentation |
| 06/25/2002 | US6410264 Pichia pastoris gene sequences and methods for their use |
| 06/25/2002 | US6410263 Histidine kinase |
| 06/25/2002 | US6410259 Fermenting microbial strains |
| 06/25/2002 | US6410250 Sustained delivery device and methods of making and using the same |
| 06/25/2002 | US6410030 Polypeptide used as immunogenic element carried by peptide sequence between amino acid residues 130 and 230 of sequence of g protein of human respiratory syncytial virus of subgroups a and b, or of bovine respiratory syncytial virus |
| 06/25/2002 | US6410013 Viral vectors for use in monitoring HIV drug resistance |
| 06/25/2002 | CA2123612C Hybrid protein between cs from plasmodium and h bsag |
| 06/25/2002 | CA2085881C Dna encoding mammalian phosphodiesterases |
| 06/25/2002 | CA2036814C Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/25/2002 | CA2017379C Purification and characterization of a glioma-derived growth factor |
| 06/25/2002 | CA2006412C Eimeria tenella vaccine |
| 06/20/2002 | WO2002048376A2 Bacterial host strains |
| 06/20/2002 | WO2002048359A1 Magnetic particle membrane-specific protein |
| 06/20/2002 | WO2002048350A1 Transformed yeast presenting cellulose-binding domain on the cell surface layer |
| 06/20/2002 | WO2002042475A8 Gene hd3a inducing flowering of plant and utilization thereof |
| 06/20/2002 | WO2001083786A3 Stable zymomonas mobilis xylose and arabinose fermenting strains |
| 06/20/2002 | WO2000077233A9 Complement-resistant non-mammalian dna viruses and uses thereof |
| 06/20/2002 | US20020078473 Pesticides |
| 06/20/2002 | US20020077468 Corticotropin-releasing factor2 receptors |
| 06/20/2002 | US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/20/2002 | US20020077457 Nucleotide sequences coding binding protein for use as diagnostic tools in genetic engineering |
| 06/20/2002 | US20020077297 Disposing cell comprising sodium channel blocker into a well, disposing fluorescent dye into well; adding sodium channel blocker, to be identified, into well; passing stimulating current to generate an action potential; optically measuring |
| 06/20/2002 | US20020076808 Use of suppressor tRNA's to regulate cytotoxicity during the production of recombinant gene products |
| 06/20/2002 | US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 06/20/2002 | US20020076772 Process for the production of xylitol |
| 06/20/2002 | US20020076771 Production of ascorbic acid |
| 06/20/2002 | US20020076751 Novel plasmid, bearing the plasmid, and method of producing an enzyme using the transformant |
| 06/20/2002 | US20020076403 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 06/20/2002 | DE10060810A1 Coniosetin und Derivate davon, Verfahren zur Herstellung und Verwendung derselben Coniosetin and derivatives thereof, methods of making and using the same |
| 06/20/2002 | CA2430249A1 Bacterial host strains |
| 06/19/2002 | EP1215212A2 Dihydro derivatives of LL-E33288 antibiotics |
| 06/19/2002 | EP1214450A2 Method and nucleic acids for determining the presence of micro-organisms specific to the brewing process |
| 06/19/2002 | EP1214440A2 Sequence-specific dna recombination in eukaryotic cells |
| 06/19/2002 | EP1214421A2 Stachybotrys phenol oxidizing enzyme |
| 06/19/2002 | EP1214420A2 Methods and microorganisms for production of panto-compounds |
| 06/19/2002 | EP1214399A1 High level cytokine production with enhanced cell viability |
| 06/19/2002 | EP1214396A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 06/19/2002 | EP1214349A2 Secreted soluble alpha2delta-2, alpha2delta-3 or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 06/19/2002 | EP1214334A1 Mutant fatty acid desaturase and methods for directed mutagenesis |
| 06/19/2002 | EP1214098A1 Capsid-modified recombinant adenovirus and methods of use |
| 06/19/2002 | EP0804616B1 Specific and universal amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 06/19/2002 | EP0714510B1 Natural killer cell-specific antigen and antibodies that identify the same |
| 06/19/2002 | EP0632817B1 Neurotrophic factors having altered receptor binding specificities |
| 06/19/2002 | EP0625204B1 Hepatitis therapeutics |
| 06/19/2002 | EP0611397B1 Feline leukemia virus vaccines |
| 06/19/2002 | EP0462215B1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 06/19/2002 | CN1354798A Process for preparation of pseudomonic acid A antibiotic by microbiological method |
| 06/19/2002 | CN1354795A Polypeptides having lactonohydrolase activity and nucleic acids encoding same |